Stonebridge Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-8,950
| Closed | -$239K | – | 117 |
|
|
2019
Q2 | $239K | Buy |
8,950
+350
| +4% | +$9.35K | 0.09% | 114 |
|
|
2019
Q1 | $231K | Sell |
8,600
-5,605
| -39% | -$151K | 0.08% | 122 |
|
|
2018
Q4 | $230K | Buy |
14,205
+1,775
| +14% | +$28.7K | 0.09% | 115 |
|
|
2018
Q3 | $258K | Sell |
12,430
-400
| -3% | -$8.3K | 0.09% | 110 |
|
|
2018
Q2 | $213K | Buy |
+12,830
| New | +$213K | 0.08% | 118 |
|
|
2016
Q2 | – | Sell |
-24,110
| Closed | -$675K | – | 131 |
|
|
2016
Q1 | $675K | Buy |
24,110
+14,720
| +157% | +$412K | 0.29% | 59 |
|
|
2015
Q4 | $334K | Buy |
+9,390
| New | +$334K | 0.14% | 120 |
|
|
2015
Q3 | – | Sell |
-6,930
| Closed | -$290K | – | 160 |
|
|
2015
Q2 | $290K | Hold |
6,930
| – | – | 0.12% | 131 |
|
|
2015
Q1 | $226K | Hold |
6,930
| – | – | 0.09% | 148 |
|
|
2014
Q4 | $220K | Buy |
+6,930
| New | +$220K | 0.08% | 162 |
|